Shares of Indian pharmaceutical major Wockhardt rallied more than 13% on Monday after it announced a milestone development in its innovation pipeline: the United States Food and Drug Administration has formally accepted its New Drug Application for Zaynich, a novel antibiotic designed to target complicated urinary tract infections caused by multi-drug resistant gram-negative bacteria. The











